INS and Alzheimer disease: The results demonstrated that zeaxanthin and lutein effectively attenuated memory impairment and other AD-like pathologies in Aβ(25-35) rats by potentially modulating neuroinflammation, hippocampal and systemic insulin resistance, and AChE activity.